AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2021

Mar 3, 2021

29755_dirs_2021-03-02_ac1645f9-6fa0-4f88-94be-cf1e9ea501b8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-02-28

Reporting Person: Gosebruch Henry O (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-28	Common Stock, $0.01 par value	F	22833	$107.74	Disposed	48711	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	48500	Indirect
Common Stock, $0.01 par value	3144	Indirect

Footnotes

F1: The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.

F2: Balance in AbbVie Savings program as of February 26, 2021.